ALSO NOTED: Guidant sold faulty defibrillator despite problems; Hormone creates trust; and much more...

> Guidant continued to sell a faulty defibrillator, even after it learned of problems with the device, The New York Times reports. Story

> Senate Majority Leader Bill Frist (R-Tenn.) tells medical students at Harvard University that the country needs a major biodefense initiative. Story

> The judge in the Scrushy trial says jurors may not see the transcript of the court case. Story

> Tuft's New England Medical Center and Children's Hospital say they won't merge. Story

> The Department of Health and Human Services is stepping up the drive to educate the public about the Medicare Part D benefit. Story

> VA hospital in Los Angeles adding ER physicians following report. Story

> A new report from the Center for Budget and Policy Priorities looks at the impact of increased cost sharing for Medicaid participants. Story

> Hospira to pay $23 million for Physiometrix. Story

> The National Institutes of Health awarded Colorado State University a $40 million grant to establish a regional center to study infectious diseases that could be used as terror weapons. Story

> An experimental vaccine developed by Merck appears to be effective at preventing shingles and reducing the pain experienced by sufferers. Story

> In Europe, researchers find many obese children are starting to develop health problems that normally afflict the middle aged. Story

> Criticism of "activist medicine." Story

And Finally... Swiss researchers report that a hormone appears to increase people's trust in strangers. Story